1. Introduction
HOST
Welcome back to Smarter Supplier Auditing for the Pharmaceutical Sector, the podcast where we explore practical approaches to strengthening supplier quality and compliance across pharmaceutical and healthcare supply chains.
In our first episode, we explained what a shared audit is and how it can help reduce duplication while maintaining robust supplier oversight.
But that naturally leads to the next question:
When should you choose a shared audit, and when is a dedicated audit the better option?
To help us answer that, I'm delighted to be joined by Anaïs Mellet from our Operations Department looking after our customers after the audit happens.
Welcome Anaïs.
GUEST
Thank you, Catherine. Great to be back.
2. Do organisations need to choose one approach?
HOST
Let's start with a common assumption.
Do organisations need to choose between shared audits and dedicated audits?
GUEST
Not at all.
In fact, the most effective supplier assurance programmes rarely rely on just one approach.
Shared audits and dedicated audits each have their place, and many pharmaceutical companies use both as part of a risk-based supplier qualification strategy.
The key question isn't which approach is better.
The question is which approach is most appropriate for a particular supplier, product, process or risk profile.
HOST
So rather than an either-or decision, it's really about selecting the right tool for the right situation?
GUEST
Exactly.
Both approaches can deliver valuable supplier oversight when used appropriately.
3. When do shared audits work particularly well?
HOST
Let's start with shared audits.
Where do they tend to offer the greatest value?
GUEST
Shared audits are often most effective where multiple pharmaceutical companies are assessing suppliers that operate mature, established quality systems and where many of the audit requirements are broadly similar.
Examples might include:
- Approved API manufacturers
- Excipients suppliers
- Packaging suppliers
- Contract laboratories
- Warehousing and distribution providers
- Existing contract manufacturers undergoing routine surveillance
In these situations, different customers often need to evaluate many of the same quality system elements.
A shared audit allows that assessment to be completed efficiently while still addressing the individual interests of each participating organisation.
HOST
And I imagine that's beneficial for suppliers as well?
GUEST
Absolutely.
Many suppliers are audited repeatedly by different customers throughout the year.
By reducing duplication, shared audits can lessen audit fatigue, minimise operational disruption and allow supplier teams to spend more time focusing on quality improvements rather than preparing for multiple audits.
4. When is a dedicated audit the better choice?
HOST
So when would a dedicated audit be the preferred option?
GUEST
So, a dedicated audit could be considered the more traditional audit approach, where an audit is conducted solely on behalf of a single organisation, with the audit scope and plan tailored entirely to that company's specific objectives, concerns and regulatory requirements.
This type of audit is particularly valuable when an organisation requires a highly focused assessment. That might be in support of a specific project, the qualification of a strategically important supplier, the review of a particular manufacturing process, or the investigation of supplier performance and quality-related concerns.
There are also a number of situations where a dedicated audit is often the preferred option. For example:
Qualification of a new high-risk supplier
Critical manufacturing processes or products
Significant regulatory concerns
Major quality events, deviations or compliance issues
In these circumstances, organisations may require a very specific audit scope and a deeper technical focus. The flexibility over the audit scope, timing and areas of focus, allowing the assessment to be aligned precisely with their business and quality objectives.
This level of customisation is what makes dedicated audits an important part of many pharmaceutical supplier assurance programmes.
A dedicated audit allows the entire assessment to be tailored to that organisation's objectives.
HOST
So the higher the risk or complexity, the more likely a dedicated audit becomes valuable?
GUEST
Generally speaking, yes.
Where the level of risk, product criticality or business impact is higher, organisations often want a more customised assessment.
5. Is cost the main driver?
HOST
One thing people often associate with shared audits is cost savings.
Should that be the primary reason for choosing them?
GUEST
Cost is certainly one benefit, but it's rarely the most important one.
Many organisations participate in shared audits because they gain access to experienced specialist auditors, achieve broader supplier coverage and can schedule audits more efficiently.
There are also benefits around consistency.
When supplier quality teams are trying to oversee large global supplier networks, shared audits can help maintain regular surveillance without creating unnecessary duplication.
HOST
So, the value goes well beyond reducing audit budgets.
GUEST
Very much so.
Most organisations are looking for an approach that maintains compliance, improves efficiency and enables better use of internal resources.
6. Building a Risk-Based Audit Programme
HOST
If there's one piece of advice you'd give listeners when deciding between the two approaches, what would it be?
GUEST
Take a risk-based view.
Consider the supplier's criticality, the products involved, regulatory expectations, business impact and the objectives of the audit.
In many cases, the best answer isn't shared or dedicated.
It's a combination of both.
That's often where organisations achieve the strongest balance between supplier oversight, efficiency and resource management.
Closing
HOST
That's a great takeaway.
Shared audits and dedicated audits aren't competing approaches. They're complementary tools that can be combined to create a stronger supplier assurance programme.
In our next episode, we'll look beyond the audit itself and explore how shared audits are helping organisations improve supplier quality, strengthen supply chain visibility and support more sustainable ways of working across global pharmaceutical networks.
GUEST
Yes, certainly …. As supply chains become larger and more complex, those topics are becoming increasingly important for supplier quality and compliance teams.
HOST
Anaïs, thank you for joining us once again.
And thank you to everyone listening.
Please watch this space as we will be announcing our next evolution of smarter audit solutions in the coming months.
Until then, join us next time for the next episode of Smarter Supplier Auditing for the Pharmaceutical Sector, where we'll explore how shared audits can contribute to more resilient, transparent and efficient supply chains.